Pregled bibliografske jedinice broj: 29265
The influence of radioprotective drug WR-2721 on acute hepatotoxicity in mouse
The influence of radioprotective drug WR-2721 on acute hepatotoxicity in mouse // Periodicum biologorum / Vitale, Branko (ur.).
Zagreb: IGP Štefanović, 1998. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 29265 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The influence of radioprotective drug WR-2721 on acute hepatotoxicity in mouse
Autori
Aleksić, Joško ; Čulo, Filip ; Morović-Vergles, Jadranka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Periodicum biologorum
/ Vitale, Branko - Zagreb : IGP Štefanović, 1998
Skup
Fourth International Meeting on Local Immunity
Mjesto i datum
Opatija, Hrvatska, 16.09.1998. - 19.09.1998
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
WR-2721; hepatotoxicity; acetaminophen
Sažetak
It is known that WR-2721 (S-2-(3-aminopropylamino)ethyl acid) have radioprotective and chemoprotrctive effects on non-tumor tissues (Treskes et al., Cancer Chemotherapy & Pharmacology.33:93-106, 1993.), and is now introduced into clinical tumor therapy protocols. We investigated whether WR-2721 have a protective role in other kinds of tissue injuri, i.e. acute liver injuri induced with acetaminophen (AAP). CBA/H Zgr inbred mice of both sexes aged 12-16 weeks, weighing 20-25 g were used. Mice were given phenobarbitone-sodium (Kemika, Zagreb, Croatia) in drinking water during 7 days (300 mg/kg) in order to induce hepatic drug -metabolizing enzymes. Thereafter, mice were feasted overnight and WR-2721 was given i.p. (50, 100 or 200 mg/kg). After 15-30 minutes they received acetaminophen (Paracetamol ; AAP) 200 mg/kg by gastric tube. Animals were alowed water 4 hours later. The mortality of mice was followed for 3 days and serum aminotransferase levels were determined 24 hours after AAP administration. Survival of mice was prolonged after all doses of WR-2721, but significantly only after the dose of 100 mg/kg of WR-2721. Similarly, the pretreatment of mice with 100 mg/kg of WR-2721 highly significantly reduced serum aspartate aminotransferase levels (AST, p<0, 0005) and serum alanine aminotransferase levels (ALT, p<0.005). The doses of 50 and 200 mg/kg of WR-2721 also reduced AST and ALT, but not significantly. These data shows that WR-2721 has definitive hepatoprotective effect, but only in very restricted dose range. Possible explanation for this may be that the lowest dose of WR-2721 is not enough protective, while the highest dose of WR-2721 may be hepatotoxic by itself, thus causing additional liver damage along with AAP. We are continuing our experiments in that direction.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb